Skip to main content
. 2012 Jun 8;1(2):153–167. doi: 10.3390/cells1020153

Table 1.

Diagnostic performance of ELISPOT-detected Borrelia-induced Interferon-γ secretion in patients with Lyme neuroborreliosis and non-Lyme neuroborreliosis, utilizing different cut-offs.

Diagnostic groups ELISPOT cut-off ≥5 spots ELISPOT cut-off ≥10 spots
Positive Negative Positive Negative
Lyme neuroborreliosis (n = 14) 5 (36%) 9 (64%) 3 (21%) 11 (79%)
Non-Lyme borreliosis (n = 103) 19 (18%) 84 (82%) 8 (8%) 95 (92%)